Autobahn Therapeutics, Inc. — Form D

Autobahn Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-08-01. The offering totals $120.0M, of which $100.8M was reported sold. Industry: Biotechnology.

Offering

Filed: 2024-08-01
Form: D
Accession: 0001815098-24-000003
Industry: Biotechnology
Exemptions: 06b
Total offering: $120.0M
Amount sold: $100.8M
Remaining: $19.2M
Investors: 22
Date of first sale: 2024-06-20
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-520406

Issuer

Name: Autobahn Therapeutics, Inc.
CIK: 0001815098
Entity type: Corporation
Jurisdiction: DELAWARE
Address: 9880 CAMPUS POINT DRIVE, SAN DIEGO, CA, 92121
Phone: 858-257-3418

Officers, directors & promoters (11)

Name	Role	Location
Timothy Anderson	Director	San Diego, CA
Kristina Burow	Director	San Diego, CA
Thomas Cahill	Director	Boston, MA
Benjamin Cravatt	Director	San Diego, CA
Philip J DeSouza	Director	San Diego, CA
Kevin Finney	Director	San Diego, CA
Scott Giacobello	Director	MORRISTOWN, NJ
Uwe J Schoenbeck	Director	San Diego, CA
Bonnie J van Wilgenburg	Director	San Diego, CA
John Borkholder	Executive Officer	San Diego, CA
Kevin Finney	Executive Officer	San Diego, CA

More